SCOLARI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.518
EU - Europa 4.250
AS - Asia 3.967
AF - Africa 432
SA - Sud America 293
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.466
Nazione #
US - Stati Uniti d'America 4.456
SG - Singapore 1.337
CN - Cina 1.205
GB - Regno Unito 1.072
IT - Italia 788
VN - Vietnam 597
SE - Svezia 547
DE - Germania 542
HK - Hong Kong 376
UA - Ucraina 340
BR - Brasile 213
IN - India 210
RU - Federazione Russa 200
FR - Francia 181
IE - Irlanda 148
NL - Olanda 140
TG - Togo 139
ZA - Sudafrica 90
NG - Nigeria 87
JP - Giappone 71
SC - Seychelles 70
EE - Estonia 61
BG - Bulgaria 59
FI - Finlandia 59
JO - Giordania 54
AR - Argentina 41
CI - Costa d'Avorio 38
CA - Canada 36
KR - Corea 31
BE - Belgio 28
IR - Iran 27
MX - Messico 21
AT - Austria 20
GR - Grecia 14
TR - Turchia 13
ES - Italia 12
BD - Bangladesh 11
CH - Svizzera 11
CO - Colombia 8
PY - Paraguay 8
EC - Ecuador 7
PL - Polonia 7
CL - Cile 6
ID - Indonesia 6
IQ - Iraq 5
MY - Malesia 5
VE - Venezuela 5
AU - Australia 4
LT - Lituania 4
RO - Romania 4
DZ - Algeria 3
KZ - Kazakistan 3
PE - Perù 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
LB - Libano 2
OM - Oman 2
PT - Portogallo 2
SM - San Marino 2
UZ - Uzbekistan 2
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
PA - Panama 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.466
Città #
Southend 949
Singapore 874
Ashburn 583
Chandler 461
Hong Kong 373
Fairfield 280
Santa Clara 252
Jacksonville 231
Beijing 201
Princeton 193
Wilmington 181
Ann Arbor 163
Dublin 145
Houston 139
Lomé 139
Woodbridge 137
Seattle 120
Dong Ket 112
Boardman 108
Nanjing 103
Hefei 102
Padova 94
Ho Chi Minh City 89
Westminster 88
Abeokuta 86
Cambridge 79
Los Angeles 73
Hanoi 72
Turin 72
Tokyo 71
Berlin 67
Sofia 59
Bremen 57
Medford 56
Amman 54
Bologna 54
Milan 52
Jinan 50
Buffalo 47
Helsinki 47
Munich 39
Saint Petersburg 39
Abidjan 38
New York 37
Guangzhou 35
Shenyang 35
Mülheim 33
Hebei 31
Changsha 30
Rome 30
Seoul 30
Redondo Beach 29
Nanchang 27
Brussels 26
Redwood City 25
Florence 24
Zhengzhou 23
Dearborn 22
Falkenstein 20
Mahé 20
Tianjin 20
Bengaluru 19
Jiaxing 19
San Diego 18
São Paulo 18
Frankfurt am Main 17
Hangzhou 17
Hyderabad 17
London 16
Taiyuan 16
Chicago 15
Toronto 15
Monmouth Junction 14
Mountain View 14
Norwalk 14
Taizhou 14
The Dalles 14
Dallas 13
Fuzhou 13
Ningbo 13
Phoenix 13
Shanghai 13
Verona 12
Wuhan 12
Haikou 11
Lanzhou 11
Mexico City 11
Stockholm 11
Turku 11
Ardabil 10
Brooklyn 10
Des Moines 10
Haiphong 10
Xi'an 10
Bari 9
Da Nang 9
Johannesburg 9
Vienna 9
Andover 8
Boston 8
Totale 8.229
Nome #
La conversione da MMF a Micofenolato sodico gastroprotetto (EC-MPS, Myfortic) migliora la sintomatologia gastrointestinale in pazienti con trapianto di rene in terapia con Tacrolimus 254
Correlazioni tra decoy cells urinarie, viremia BK e terapia immunosoppressiva nel trapianto di rene 235
Cardiovascular Disease in Kidney Transplant Recipients: The Prognostic Value of Inflammatory Cytokine Genotypes. 233
Advagraf vs Prograf immunosuppressive therapy in de novo kidney transplant: a single center experience 232
A comparative study of renal preservation for the prevention of ischemia/reperfusion injury: Machine Perfusion versus Cold Storage in a porcine autotransplant model. 226
Anemia secondaria ad infezione da Parvovirus B19 nel trapianto renale 200
Delayed Graft Function (DGF) e Trapianto Renale: studio dei principali fattori di rischio. 197
Nephrological indications in combined liver kidney transplantation 188
Impact of cytokines and apoptosis molecules polymorphisms on Chronic Allograft Nephropathy 185
COMBINED KIDNEY LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE 184
An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury. 180
Combined liver-kidney transplantation-s. Orsola experience: nephrological aspects. 179
INDICAZIONI NEFROLOGICHE AL TRAPIANTO COMBINATO RENE-FEGATO 176
Differentiation of mesenchymal stem cells into renal precursors 176
Genetic Factors and Risk OF Acute Rejection in Kidney Transplant 175
Incidence of cancer in kidney transplantation waiting list patients: a single center experience. 175
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 173
Reduction of Oxidative Damage Reflects a Better Kidney Transplantation Outcome. 170
INFLUENCE OF DELAYED GRAFT FUNCTION (DGF) ON RENAL TRANSPLANTATION OUTCOME 168
The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes 166
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 165
Molecular markers in the early diagnosis of Acute Rejection after renal transplant 163
Trapianto Combinato Rene-Fegato: Esperienza del Policlinico S.Orsola di Bologna 163
A very early and acute renal impairment due to polyomavirus allograft nephropathy. 163
Marcatori molecolari precoci di Rigetto Acuto nel Trapianto di Rene 162
Doppio Trapianto Renale: Esperienza di un Centro Trapianti 162
Schemi di terapia immunosoppressiva e livelli ematici consigliati 162
Effects of FTY720 on lymphocyte subsets expressing different homing receptors in kidney tranplantation 161
Incidenza di Rigetto Acuto nel Trapianto Renale: ruolo dei fattori genetici 160
Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible? 159
Chronic allograft dysfunction: role of immunosuppressive treatment 158
Cellule staminali mesenchimali in cloni di progenitori renali: fenotipo metanefrico 158
Rigetto ed espressione di geni “housekeeping” nel Trapianto di Rene. 157
Epatopatia e trapianto renale: esperienza a medio-lungo termine 154
Il Percorso di certificazione UNI EN ISO 9001:2000 di un Programma di Trapianto Renale. 151
Expanding the Evidence Base in Transplantation: The Complementary Roles of Randomized Controlled Trials and Outcomes Research. 148
Expression of markers for metanephric differentiation induced by butyric and hyaluronic esters 147
Influence of delayed graft function (DGF) on renal transplantation outcome 147
Chronic allograft nephropathy - a clinical syndrome: Early detection and the potential role of proliferation signal inhibitors 147
The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. 147
Nephrological indications in combined liver-kidney transplantation. 147
Polimorfismo del Vascular Endothelial Growth Factor e rischio cardiovascolare dopo trapianto renale 146
Efficacy and appropriateness of histological score in prediction of the 3-year outcome of kidney transplantation 142
Metabolic syndrome after kidney transplantation. 140
Predictive factors in chronic allograft nephropathy 139
Combined liver kidney transplantation: St. Orsola experience 138
Score istologico pre-trapianto e outcome del trapianto renale 137
Fattori di rischio genetici per la patologia cardiovascolare dopo trapianto di rene: ruolo dei polimorfismi delle citochine 136
Double kidney transplantation: initial experience of the Bologna Transplant Center. 136
Therapy strategies in the prevention of chronic allograft nephropathy 135
Perfusione Continua versus Ipotermia Semplice nel Trapianto d’organo. Studio sperimentale su modello animale. 135
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin. 134
Term placenta human mesenchymal stem cells treated with butyric and hyaluronic esters express markers for metanephric differentiation and protect against ischemia-reperfusion kidney injury in rats 133
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study. 131
Genetic variability and cardiovascular risk in renal transplant recipients 130
Il Trapianto Combinato Rene-Fegato: esperienza monocentrica a lungo termine 130
Expression of metanephric differentiation markers in human mesenchymal stem cells. [Marker di differenziamento metanefrico espressi in cellule staminali mesenchimanli umane]. 128
Potenziali applicazioni delle cellule staminali nelle patologie renali: impiego di molecole sintetiche per il differenziamento in progenitori renali 127
FTY720 nel trapianto renale: caratterizzazione molecolare dei processi di homing dei linfociti circolanti 125
Calcineurin inhibitors in renal transplantation still needed but in reduced doses: a review. 125
Tacrolimus-associated myositis: a case report in a renal transplant patient. 124
Prevenire e ridurre le comorbilità nei candidati per aumentare la durata del rene trapiantato 123
GENETIC FACTORS AND RISK OF CHRONIC ALLOGRAFT NEPHROPATHY IN KIDNEY TRANSPLANT 123
Low-toxicity immunosuppressive therapy in renal transplant. [Il successo del trapianto di rene dipende anche da una terapia efficace a bassa tossicità]. 122
Factors determining cardiovascular disease progression after kidney transplant 122
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 120
Expression of markers for metanephric differentiation induced by butyric and hyaluronic esters 119
Trapianto di rene a Bologna 119
Role of killer-cell immunoglobulin-like receptor and human leucocyte antigen in kidney transplantation 118
Advantages and challenges for use of Registries for transplant outcomes research 118
Incidenza di Nefropatia Cronica da Trapianto: possibile ruolo dei polimorfismi genetici di citochine infiammatorie e di molecole di apoptosi 117
INCIDENCE OF LATE DEEP VENOUS THROMBOSIS IN RENAL TRANSPLANT RECIPIENTS 117
Expression of markers for metanephric differentiation induced by butyric and hyaluronic esters 115
Oxidative stress in kidney transplant recipients 113
Prospective study on the clinical and prognostic significance of Polyomavirus JC infection in kidney transplant 113
Killer-cell immunoglobulin-like receptor genes and ligands in kidney transplant 112
Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 111
IMPACT OF CYTOKINE AND APOPTOSIS GENE POLYMORPHISMS ON ACUTE GRAFT REJECTION AFTER KIDNEY TRANSPLANT 109
Kidney transplantation in highly immunized patients: ten years of follow-up 109
Increase of T cell subsets expressing markers of activation and cytoxicity in patients with post-transplant malignancy 109
Long-term results of combined Liver-Kidney Transplantation: a single-center experience 108
Genetic variability and cardiovascular risk in renal transplant recipients 106
La valutazione clinica del donatore vivente 106
INFLUENCE OF APOPTOSIS AND INFLAMMATION GENE POLYMORPHISMS ON TRANSPLANTED KIDNEY FUNCTION 104
NGAL as a marker of renal damage in kidney transplantation 95
Preliminary results from a prospective multicenter study reveal the early appearance of de novo anti-HLA antibodies following renal transplantation 76
Miglioramento della sintomatologia gastrointestinale in pazienti con trapianto renale stabile dopo conversione da MMF a Micofenolato sodico gastroprotetto (EC-MPS, Myfortic) 65
Randomized trial of sodium mycophenolate (MPS) and basiliximab in combination with reduced or standard cyclosporine (CsA) in old recipents of kydney transplant (KTX) 65
Membranes, technologies and long-term results in chronic haemodialysis 51
Preventing and reducing comorbidity in candidates for kidney transplantation for the improvement of post-operative results 48
Sudeck's atrophy of the left tibiotarsal joint in a renal transplant patient: Effects of medical and physical therapy 48
Review of 20 years' clinical experience with living donor kidney transplantation at the Polyclinic of St. Orsola 43
Mismatch-specific anti-HLA antibody production following aorta transplants 41
Immune response following fresh arterial homograft replacement for aortoiliac graft infection 40
ELISA anti-HLA antibody screening identifies non-complement-fixing antibodies responsible for acute graft rejection. A case report 40
Funzione ritardata del trapianto renale da danno ischemico reversibile. Fattori di rischio e prognosi a breve e a lungo termine 36
Is Ace inhibitor treatment a possible cause of better cardiovascular remodelling in well functioning kidney transplant? 36
Crossmatch testing in renal transplantation: Comparative evaluation between an innovatory ELISA technique and two different standardised CDC methods 35
[Renal transplantation and malignancies: A single-centre experience (25 years)] 34
Application of flow cytometry in clinical renal transplantation 31
Totale 13.241
Categoria #
all - tutte 34.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021769 0 0 0 0 0 72 24 73 103 70 66 361
2021/20221.629 164 119 96 124 149 111 20 86 51 83 325 301
2022/20232.188 213 371 126 262 190 168 64 97 351 62 204 80
2023/2024603 34 77 32 87 50 139 33 55 7 30 16 43
2024/20252.402 91 316 191 127 425 121 212 87 45 195 40 552
2025/20262.643 432 426 406 342 731 306 0 0 0 0 0 0
Totale 13.628